ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 225 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2019. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $262,061 | -81.3% | 24,982 | -76.5% | 0.00% | -100.0% |
Q3 2023 | $1,398,192 | +53.4% | 106,407 | +47.1% | 0.00% | +50.0% |
Q2 2023 | $911,278 | -9.4% | 72,324 | -6.2% | 0.00% | 0.0% |
Q1 2023 | $1,005,765 | +5.4% | 77,071 | +42.5% | 0.00% | 0.0% |
Q4 2022 | $954,359 | -53.6% | 54,097 | -60.0% | 0.00% | -60.0% |
Q3 2022 | $2,057,000 | +77.6% | 135,114 | +73.0% | 0.01% | +66.7% |
Q2 2022 | $1,158,000 | -63.8% | 78,093 | -45.0% | 0.00% | -50.0% |
Q1 2022 | $3,197,000 | +174.0% | 142,011 | +124.5% | 0.01% | +200.0% |
Q4 2021 | $1,167,000 | +38.8% | 63,247 | +0.6% | 0.00% | 0.0% |
Q3 2021 | $841,000 | -29.2% | 62,887 | -2.0% | 0.00% | -33.3% |
Q2 2021 | $1,188,000 | +21.6% | 64,172 | -1.4% | 0.00% | +50.0% |
Q1 2021 | $977,000 | +1.8% | 65,077 | -2.1% | 0.00% | 0.0% |
Q4 2020 | $960,000 | +71.1% | 66,453 | -3.5% | 0.00% | 0.0% |
Q3 2020 | $561,000 | -32.7% | 68,895 | -44.0% | 0.00% | -33.3% |
Q2 2020 | $834,000 | -67.2% | 123,128 | -65.9% | 0.00% | -66.7% |
Q1 2020 | $2,541,000 | -21.1% | 360,945 | +10.0% | 0.01% | -10.0% |
Q4 2019 | $3,220,000 | +14.8% | 328,069 | +28.4% | 0.01% | +42.9% |
Q3 2019 | $2,805,000 | -14.1% | 255,494 | -9.0% | 0.01% | -36.4% |
Q2 2019 | $3,265,000 | +27.0% | 280,675 | +4.3% | 0.01% | +22.2% |
Q1 2019 | $2,570,000 | +53.8% | 269,176 | +122.9% | 0.01% | +50.0% |
Q4 2018 | $1,671,000 | -3.2% | 120,747 | -0.5% | 0.01% | 0.0% |
Q3 2018 | $1,727,000 | +466.2% | 121,359 | +378.0% | 0.01% | +500.0% |
Q2 2018 | $305,000 | -93.6% | 25,391 | -93.4% | 0.00% | -94.4% |
Q1 2018 | $4,772,000 | -50.9% | 386,392 | -42.1% | 0.02% | -47.1% |
Q4 2017 | $9,716,000 | -9.6% | 667,834 | -11.6% | 0.03% | -10.5% |
Q3 2017 | $10,751,000 | +3.8% | 755,617 | -6.9% | 0.04% | -7.3% |
Q2 2017 | $10,359,000 | +60.2% | 811,857 | +59.2% | 0.04% | +46.4% |
Q1 2017 | $6,467,000 | +51.7% | 510,054 | +22.1% | 0.03% | +33.3% |
Q4 2016 | $4,264,000 | -15.2% | 417,636 | +9.4% | 0.02% | -19.2% |
Q3 2016 | $5,026,000 | +35.5% | 381,656 | +30.7% | 0.03% | +18.2% |
Q2 2016 | $3,708,000 | -25.6% | 291,912 | -22.6% | 0.02% | -29.0% |
Q1 2016 | $4,981,000 | -18.5% | 377,064 | -5.1% | 0.03% | -16.2% |
Q4 2015 | $6,110,000 | +28.5% | 397,249 | +3.6% | 0.04% | -15.9% |
Q3 2015 | $4,755,000 | +159.7% | 383,444 | +186.5% | 0.04% | +158.8% |
Q2 2015 | $1,831,000 | +13984.6% | 133,831 | +11517.3% | 0.02% | – |
Q1 2015 | $13,000 | +160.0% | 1,152 | +172.3% | 0.00% | – |
Q4 2014 | $5,000 | – | 423 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 11,000,000 | $163,570,000 | 8.77% |
Blue Harbour Group | 7,262,346 | $107,991,000 | 8.08% |
RIVULET CAPITAL, LLC | 265,000 | $3,941,000 | 4.12% |
Breithorn Capital Management | 336,760 | $5,008,000 | 2.92% |
EMINENCE CAPITAL, LP | 7,791,132 | $115,854,000 | 2.56% |
Chinook Capital Management | 76,275 | $1,134,000 | 1.73% |
GARGOYLE INVESTMENT ADVISOR L.L.C. | 198,008 | $2,657,000 | 1.64% |
Adirondack Research & Management Inc. | 190,749 | $2,836,000 | 1.63% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 100,000 | $1,487,000 | 1.05% |
PRICE MICHAEL F | 477,500 | $7,100,000 | 0.94% |